Lipid abnormalities and lipid-based repair strategies in atopic dermatitis

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 3, 2014, Pages 323-330

  Elias, Peter M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimicrobial peptide; Atopic dermatitis; Barrier function; Filaggrin; pH; Serine protease inhibitor

Indexed keywords

BETA DEFENSIN 2; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CERAMIDE; DESMOGLEIN 3; FATTY ACID; FATTY ACID TRANSPORTER 4; FILAGGRIN; FILAGGRIN 2; GLUCOCORTICOID; ICOSAPENTAENOIC ACID; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; KERATIN; KERATOHYALIN; LINOLENIC ACID; PHOSPHOLIPASE A2; PRIMROSE OIL; PROFILAGGRIN; PROTEIN S 100; SERINE PROTEINASE; SKIN LIPID; SPHINGOMYELIN; STERYL SULFATASE; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ATOPIC DERMATITIS; DISEASE ASSOCIATION; DOWN REGULATION; ESSENTIAL FATTY ACID DEFICIENCY; FAT INTAKE; HORNERIN; HUMAN; ICHTHYOSIS VULGARIS; INFLAMMATION; LAMELLAR BODY; LIPID COMPOSITION; LIPID TRANSPORT; LOSS OF FUNCTION MUTATION; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REVIEW; SKIN PENETRATION; STRATUM CORNEUM; TH1 CELL; TH2 CELL;

ANTIMICROBIAL PEPTIDE; ATOPIC DERMATITIS; BARRIER FUNCTION; FILAGGRIN; PH; SERINE PROTEASE INHIBITOR;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; DERMATITIS, ATOPIC; EPIDERMIS; HUMANS; IMMUNOGLOBULIN E; LIPID METABOLISM; LIPIDS; MAST CELLS; TH1 CELLS; TH2 CELLS;

EID: 84896701729     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2013.10.001     Document Type: Review

References (121)

1. J.L. Sugarman, J.W. Fluhr, A.J. Fowler, T. Bruckner, T.L. Diepgen, and M.L. Williams The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease Arch. Dermatol. 139 2003 1417 1422 (Pubitemid 37433131)
2. S. Seidenari, and G. Giusti Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin Acta Derm. Venereol. 75 1995 429 433 (Pubitemid 26051887)
3. E. Proksch, R. Folster-Holst, and J.M. Jensen Skin barrier function, epidermal proliferation and differentiation in eczema J. Dermatol. Sci. 43 2006 159 169 (Pubitemid 44189201)
4. S.L. Chamlin, J. Kao, I.J. Frieden, M.Y. Sheu, A.J. Fowler, J.W. Fluhr, M.L. Williams, and P.M. Elias Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity J. Am. Acad. Dermatol. 47 2002 198 208
5. B.S. Baker The role of microorganisms in atopic dermatitis Clin. Exp. Immunol. 144 2006 1 9
6. P.M. Elias, L.C. Wood, and K.R. Feingold Epidermal pathogenesis of inflammatory dermatoses Am. J. Contact Dermat. 10 1999 119 126 (Pubitemid 29416060)
7. P.M. Elias, and K.R. Feingold Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications Arch. Dermatol. 137 2001 1079 1081 (Pubitemid 32756467)
8. A. Taieb Hypothesis: from epidermal barrier dysfunction to atopic disorders Contact Dermatitis 41 1999 177 180 (Pubitemid 29427906)
9. R. Grimalt, V. Mengeaud, and F. Cambazard The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study Dermatology 214 2007 61 67 (Pubitemid 46033003)
10. P.M. Elias Stratum corneum defensive functions: an integrated view J. Invest. Dermatol. 125 2005 183 200 (Pubitemid 41648149)
11. P.M. Elias The skin barrier as an innate immune element Sem Immunopath 29 2007 3 14 (Pubitemid 47596384)
12. P.M. Elias, and G.K. Menon Structural and lipid biochemical correlates of the epidermal permeability barrier Adv. Lipid Res. 24 1991 1 26
13. K.R. Feingold Lamellar bodies: the key to cutaneous barrier function J. Invest. Dermatol. 132 2012 1951 1953
14. C. Caubet, N. Jonca, M. Brattsand, M. Guerrin, D. Bernard, R. Schmidt, T. Egelrud, M. Simon, and G. Serre Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7 J. Invest. Dermatol. 122 2004 1235 1244 (Pubitemid 38651099)
15. M. Brattsand, K. Stefansson, C. Lundh, Y. Haasum, and T. Egelrud A proteolytic cascade of kallikreins in the stratum corneum J. Invest. Dermatol. 124 2005 198 203 (Pubitemid 40100969)
16. T.K. Lin, D. Crumrine, L.D. Ackerman, J.L. Santiago, T. Roelandt, Y. Uchida, M. Hupe, G. Fabrias, J.L. Abad, R.H. Rice, and P.M. Elias Cellular changes that accompany shedding of human corneocytes J. Invest. Dermatol. 132 2012 2430 2439
17. M.H. Braff, A. Di Nardo, and R.L. Gallo Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies J. Invest. Dermatol. 124 2005 394 400 (Pubitemid 40175887)
18. A. Oren, T. Ganz, L. Liu, and T. Meerloo In human epidermis, beta-defensin 2 is packaged in lamellar bodies Exp. Mol. Pathol. 74 2003 180 182 (Pubitemid 36438667)
19. K.M. Aberg, M.Q. Man, R.L. Gallo, T. Ganz, D. Crumrine, B.E. Brown, E.H. Choi, D.K. Kim, J.M. Schroder, K.R. Feingold, and P.M. Elias Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers J. Invest. Dermatol. 128 2008 917 925 (Pubitemid 351374295)
20. A.D. Irvine, and W.H. McLean Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis J. Invest. Dermatol. 126 2006 1200 1202 (Pubitemid 43997892)
21. T.J. Hudson Skin barrier function and allergic risk Nat. Genet. 38 2006 399 400
22. A.M. Lynley, and B.A. Dale The characterization of human epidermal filaggrin. A histidine-rich, keratin filament-aggregating protein Biochim. Biophys. Acta 744 1983 28 35 (Pubitemid 13101039)
23. C.R. Harding, and I.R. Scott Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation J. Mol. Biol. 170 1983 651 673 (Pubitemid 14241851)
24. P. Fleckman, B.A. Dale, and K.A. Holbrook Profilaggrin, a high-molecular-weight precursor of filaggrin in human epidermis and cultured keratinocytes J. Invest. Dermatol. 85 1985 507 512 (Pubitemid 16204221)
25. M. Takahashi, T. Tezuka, and N. Katunuma Filaggrin linker segment peptide and cystatin alpha are parts of a complex of the cornified envelope of epidermis Arch. Biochem. Biophys. 329 1996 123 126 (Pubitemid 26143405)
26. P.M. Steinert, and L.N. Marekov The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope J. Biol. Chem. 270 1995 17702 17711
27. I.R. Scott, C.R. Harding, and J.G. Barrett Histidine-rich protein of the keratohyalin granules. Source of the free amino acids, urocanic acid and pyrrolidone carboxylic acid in the stratum corneum Biochim. Biophys. Acta 719 1982 110 117 (Pubitemid 13223076)
28. A.V. Rawlings, I.R. Scott, C.R. Harding, and P.A. Bowser Stratum corneum moisturization at the molecular level J. Invest. Dermatol. 103 1994 731 741
29. A.D. Irvine, W.H. McLean, and D.Y. Leung Filaggrin mutations associated with skin and allergic diseases N. Engl. J. Med. 365 2011 1315 1327
30. G.M. O'Regan, A. Sandilands, W.H. McLean, and A.D. Irvine Filaggrin in atopic dermatitis J. Allergy Clin. Immunol. 122 2008 689 693
31. A. Sandilands, F.J. Smith, A.D. Irvine, and W.H. McLean Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis J. Invest. Dermatol. 127 2007 1282 1284 (Pubitemid 46763004)
32. R. Gruber, P.M. Elias, D. Crumrine, T.K. Lin, J.M. Brandner, J.P. Hachem, R.B. Presland, P. Fleckman, A.R. Janecke, A. Sandilands, W.H. McLean, P.O. Fritsch, M. Mildner, E. Tschachler, and M. Schmuth Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function Am. J. Pathol. 178 2011 2252 2263
33. J.P. Thyssen, E. Godoy-Gijon, and P.M. Elias Ichthyosis vulgaris: the filaggrin mutation disease Br. J. Dermatol. 168 2013 1155 1166
34. P. Fleckman, and S. Brumbaugh Absence of the granular layer and keratohyalin define a morphologically distinct subset of individuals with ichthyosis vulgaris Exp. Dermatol. 11 2002 327 336 (Pubitemid 36934663)
35. M.D. Howell, B.E. Kim, P. Gao, A.V. Grant, M. Boguniewicz, A. Debenedetto, L. Schneider, L.A. Beck, K.C. Barnes, and D.Y. Leung Cytokine modulation of atopic dermatitis filaggrin skin expression J. Allergy Clin. Immunol. 120 2007 150 155 (Pubitemid 46990506)
36. T. Bieber Atopic dermatitis N. Engl. J. Med. 358 2008 1483 1494
37. J.M. Jensen, E. Proksch, and P.M. Elias The stratum corneum of the epidermis in atopic dermatitis P.M. Elias, K.R. Feingold, Skin Barrier 2005 Marcel Dekker New York 569 590
38. J.M. Jungersted, L.I. Hellgren, G.B. Jemec, and T. Agner Lipids and skin barrier function - a clinical perspective Contact Dermatitis 58 2008 255 262 (Pubitemid 351537624)
39. M.D. Howell The role of human beta defensins and cathelicidins in atopic dermatitis Curr. Opin. Allergy Clin. Immunol. 7 2007 413 417 (Pubitemid 47415285)
40. E.K. Greisenegger, F. Zimprich, A. Zimprich, A. Gleiss, and T. Kopp Association of the chromosome 11q13.5 variant with atopic dermatitis in Austrian patients Eur. J. Dermatol. 23 2013 142 145
41. L. Pellerin, J. Henry, C.Y. Hsu, S. Balica, C. Jean-Decoster, M.C. Mechin, B. Hansmann, E. Rodriguez, S. Weindinger, A.M. Schmitt, G. Serre, C. Paul, and M. Simon Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin J. Allergy Clin. Immunol. 131 2013 1094 1102
42. D. Khnykin, J. Ronnevig, M. Johnsson, J.C. Sitek, H.G. Blaas, I. Hausser, F.E. Johansen, and F.L. Jahnsen Ichthyosis prematurity syndrome: clinical evaluation of 17 families with a rare disorder of lipid metabolism J. Am. Acad. Dermatol. 66 2012 606 616
43. T. Sasaki, A. Shiohama, A. Kubo, H. Kawasaki, A. Ishida-Yamamoto, T. Yamada, T. Hachiya, A. Shimizu, H. Okano, J. Kudoh, and M. Amagai A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis J. Allergy Clin. Immunol. 2013 (in press)
44. S.E. Lee, S.K. Jeong, and S.H. Lee Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis Yonsei Med. J. 51 2010 808 822
45. A.J. Walley, S. Chavanas, M.F. Moffatt, R.M. Esnouf, B. Ubhi, R. Lawrence, K. Wong, G.R. Abecasis, E.Y. Jones, J.I. Harper, A. Hovnanian, and W.O. Cookson Gene polymorphism in Netherton and common atopic disease Nat. Genet. 29 2001 175 178 (Pubitemid 32952654)
46. J.P. Hachem, F. Wagberg, M. Schmuth, D. Crumrine, W. Lissens, A. Jayakumar, E. Houben, T.M. Mauro, G. Leonardsson, M. Brattsand, T. Egelrud, D. Roseeuw, G.L. Clayman, K.R. Feingold, M.L. Williams, and P.M. Elias Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome J. Invest. Dermatol. 126 2006 1609 1621
47. Y. Vasilopoulos, M.J. Cork, R. Murphy, H.C. Williams, D.A. Robinson, G.W. Duff, S.J. Ward, and R. Tazi-Ahnini Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis J. Invest. Dermatol. 123 2004 62 66 (Pubitemid 38833464)
48. T. Hubiche, C. Ged, A. Benard, C. Leaute-Labreze, K. McElreavey, H. de Verneuil, A. Taieb, and F. Boralevi Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort Acta Derm. Venereol. 87 2007 499 505 (Pubitemid 351373393)
49. R. Folster-Holst, M. Stoll, W.A. Koch, J. Hampe, E. Christophers, and S. Schreiber Lack of association of SPINK5 polymorphisms with nonsyndromic atopic dermatitis in the population of Northern Germany Br. J. Dermatol. 152 2005 1365 1367 (Pubitemid 40933452)
50. J.P. Hachem, D. Crumrine, J. Fluhr, B.E. Brown, K.R. Feingold, and P.M. Elias pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion J. Invest. Dermatol. 121 2003 345 353 (Pubitemid 36969909)
51. A. Di Nardo, P. Wertz, A. Giannetti, and S. Seidenari Ceramide and cholesterol composition of the skin of patients with atopic dermatitis Acta Derm. Venereol. 78 1998 27 30 (Pubitemid 28103674)
52. G. Imokawa, A. Abe, K. Jin, Y. Higaki, M. Kawashima, and A. Hidano Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 96 1991 523 526
53. P.M. Elias, and J.S. Wakefield Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis Clin. Rev. Allergy Immunol. 41 2011 282 295
54. P.M. Elias, R. Sun, A.R. Eder, J.S. Wakefield, and M.Q. Man Treating atopic dermatitis at the source: corrective barrier repair therapy based upon new pathogenic insights Exp. Rev. Dermatol. 8 2013 27 36
55. J.M. Jungersted, H. Scheer, M. Mempel, H. Baurecht, L. Cifuentes, J.K. Hogh, L.I. Hellgren, G.B. Jemec, T. Agner, and S. Weidinger Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema Allergy 65 2010 911 918
56. M. Schmuth, R. Gruber, E. PM, and M. Williams Ichthyosis update: towards a function-driven model of pathogenesis of the disorders of cornification and the role of corneocyte proteins in these disorders Adv. Dermatol. 23 2007 231 256
57. R. Gruber, A. Janecke, M. Rabl, V. Oji, H. Traupe, A. Sandilands, W. McLean, G. Utermann, and M. Schmuth R501X, 2282del4 and R2447X founder mutations in the filaggrin gene in European ichthyosis vulgaris patients IID 2008 Kyoto, Japan 2008
58. M.Q. Man, Y. Hatano, S.H. Lee, M. Man, S. Chang, K.R. Feingold, D.Y. Leung, W. Holleran, Y. Uchida, and P.M. Elias Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges J. Invest. Dermatol. 128 2008 79 86 (Pubitemid 350249387)
59. J.P. Hachem, E. Houben, D. Crumrine, M.Q. Man, N. Schurer, T. Roelandt, E.H. Choi, Y. Uchida, B.E. Brown, K.R. Feingold, and P.M. Elias Serine protease signaling of epidermal permeability barrier homeostasis J. Invest. Dermatol. 126 2006 2074 2086
60. G. Imokawa A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide J. Dermatol. Sci. 55 2009 1 9
61. K. Kita, N. Sueyoshi, N. Okino, M. Inagaki, H. Ishida, M. Kiso, S. Imayama, T. Nakamura, and M. Ito Activation of bacterial ceramidase by anionic glycerophospholipids: possible involvement in ceramide hydrolysis on atopic skin by Pseudomonas ceramidase Biochem. J. 362 2002 619 626 (Pubitemid 34242312)
62. Y. Ohnishi, N. Okino, M. Ito, and S. Imayama Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis Clin. Diagn. Lab. Immunol. 6 1999 101 104 (Pubitemid 29035648)
63. J. Arikawa, M. Ishibashi, M. Kawashima, Y. Takagi, Y. Ichikawa, and G. Imokawa Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus J. Invest. Dermatol. 119 2002 433 439 (Pubitemid 35001954)
64. N. Loiseau, Y. Obata, S. Moradian, H. Sano, S. Yoshino, K. Aburai, K. Takayama, J. Sakamoto, W.M. Holleran, P.M. Elias, and Y. Uchida Altered sphingoid base profiles predict compromised membrane structure and permeability in atopic dermatitis J. Dermatol. Sci. 2013 (in press)
65. Y. Hatano, Y. Adachi, P.M. Elias, D. Crumrine, T. Sakai, R. Kurahashi, K. Katagiri, and S. Fujiwara The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis Exp. Dermatol. 22 2013 30 35
66. R. Kurahashi, Y. Hatano, and K. Katagiri IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo J. Invest. Dermatol. 128 2008 1329 1331 (Pubitemid 351543188)
67. E. Sawada, N. Yoshida, A. Sugiura, and G. Imokawa Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis J. Dermatol. Sci. 68 2012 25 35
68. S. Altrichter, E. Kriehuber, J. Moser, R. Valenta, T. Kopp, and G. Stingl Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis J. Invest. Dermatol. 128 2008 2232 2239
69. E. Proksch, J.M. Brandner, and J.M. Jensen The skin: an indispensable barrier Exp. Dermatol. 17 2008 1063 1072
70. P.M. Elias, Y. Hatano, and M.L. Williams Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms J. Allergy Clin. Immunol. 121 2008 1337 1343
71. J. Ishikawa, H. Narita, N. Kondo, M. Hotta, Y. Takagi, Y. Masukawa, T. Kitahara, Y. Takema, S. Koyano, S. Yamazaki, and A. Hatamochi Changes in the ceramide profile of atopic dermatitis patients J. Invest. Dermatol. 130 2010 2511 2514
72. Y.H. Park, W.H. Jang, J.A. Seo, M. Park, T.R. Lee, D.K. Kim, and K.M. Lim Decrease of ceramides with very long-chain fatty acids and downregulation of elongases in a murine atopic dermatitis model J. Invest. Dermatol. 132 2012 476 479
73. M. Janssens, J. van Smeden, G.S. Gooris, W. Bras, G. Portale, P.J. Caspers, R.J. Vreeken, T. Hankemeier, S. Kezic, R. Wolterbeek, A.P. Lavrijsen, and J.A. Bouwstra Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients J. Lipid Res. 53 2012 2755 2766
74. M. Janssens, J. van Smeden, G.S. Gooris, W. Bras, G. Portale, P.J. Caspers, R.J. Vreeken, S. Kezic, A.P. Lavrijsen, and J.A. Bouwstra Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema J. Invest. Dermatol. 131 2011 2136 2138
75. C. Tawada, H. Kanoh, M. Nakamura, Y. Mizutani, T. Fujisawa, Y. Banno, and M. Seishima Interferon-gamma decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis J. Invest. Dermatol. 2013 (in press)
76. K.L. Hon, A.K. Leung, and B. Barankin Barrier repair therapy in atopic dermatitis: an overview Am. J. Clin. Dermatol. 14 5 2013 389 399
77. M.J. Cork, S.G. Danby, Y. Vasilopoulos, J. Hadgraft, M.E. Lane, M. Moustafa, R.H. Guy, A.L. Macgowan, R. Tazi-Ahnini, and S.J. Ward Epidermal barrier dysfunction in atopic dermatitis J. Invest. Dermatol. 129 2009 1892 1908
78. E. Nylander-Lundqvist, O. Back, and T. Egelrud IL-1 beta activation in human epidermis J. Immunol. 157 1996 1699 1704 (Pubitemid 126449113)
79. L.C. Wood, S.M. Jackson, P.M. Elias, C. Grunfeld, and K.R. Feingold Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice J. Clin. Invest. 90 1992 482 487
80. P.M. Elias, J.C. Ansel, L.D. Woods, and K.R. Feingold Signaling networks in barrier homeostasis. The mystery widens Arch. Dermatol. 132 1996 1505 1506 (Pubitemid 26424553)
81. P.M. Elias, and M. Steinhoff "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis J. Invest. Dermatol. 128 2008 1067 1070 (Pubitemid 351543225)
82. H. Bisgaard, A. Simpson, C.N. Palmer, K. Bonnelykke, I. McLean, S. Mukhopadhyay, C.B. Pipper, L.B. Halkjaer, B. Lipworth, J. Hankinson, A. Woodcock, and A. Custovic Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure PLoS Med. 5 2008 e131
83. S.K. Jeong, H.J. Kim, J.K. Youm, S.K. Ahn, E.H. Choi, M.H. Sohn, K.E. Kim, J.H. Hong, D.M. Shin, and S.H. Lee Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery J. Invest. Dermatol. 128 2008 1930 1939 (Pubitemid 352001196)
84. N. Novak, H. Baurecht, T. Schafer, E. Rodriguez, S. Wagenpfeil, N. Klopp, J. Heinrich, H. Behrendt, J. Ring, E. Wichmann, T. Illig, and S. Weidinger Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel J. Invest. Dermatol. 128 2008 1430 1435 (Pubitemid 351693185)
85. P.M. Schlievert, L.C. Case, K.L. Strandberg, B.B. Abrams, and D.Y. Leung Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis Clin. Infect. Dis. 46 2008 1562 1567 (Pubitemid 351720866)
86. D.Y. Leung, R. Harbeck, P. Bina, R.F. Reiser, E. Yang, D.A. Norris, J.M. Hanifin, and H.A. Sampson Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens J. Clin. Invest. 92 1993 1374 1380 (Pubitemid 23273913)
87. H. Lomholt, K.E. Andersen, and M. Kilian Staphylococcus aureus clonal dynamics and virulence factors in children with atopic dermatitis J. Invest. Dermatol. 125 2005 977 982
88. J. Wehner, and K. Neuber Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema Br. J. Dermatol. 145 2001 302 305 (Pubitemid 32955360)
89. E. Sonkoly, A. Muller, A.I. Lauerma, A. Pivarcsi, H. Soto, L. Kemeny, H. Alenius, M.C. Dieu-Nosjean, S. Meller, J. Rieker, M. Steinhoff, T.K. Hoffmann, T. Ruzicka, A. Zlotnik, and B. Homey IL-31: a new link between T cells and pruritus in atopic skin inflammation J. Allergy Clin. Immunol. 117 2006 411 417 (Pubitemid 43192023)
90. S.J. Miller, R. Aly, H.R. Shinefeld, and P.M. Elias In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids Arch. Dermatol. 124 1988 209 215 (Pubitemid 18054501)
91. D.J. Bibel, R. Aly, and H.R. Shinefield Antimicrobial activity of sphingosines J. Invest. Dermatol. 98 1992 269 273
92. P.Y. Ong, T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R.L. Gallo, and D.Y. Leung Endogenous antimicrobial peptides and skin infections in atopic dermatitis N. Engl. J. Med. 347 2002 1151 1160
93. I. Nomura, E. Goleva, M.D. Howell, Q.A. Hamid, P.Y. Ong, C.F. Hall, M.A. Darst, B. Gao, M. Boguniewicz, J.B. Travers, and D.Y. Leung Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes J. Immunol. 171 2003 3262 3269 (Pubitemid 37093553)
94. M.J. Cork, D.A. Robinson, Y. Vasilopoulos, A. Ferguson, M. Moustafa, A. MacGowan, G.W. Duff, S.J. Ward, and R. Tazi-Ahnini New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions J. Allergy Clin. Immunol. 118 2006 3 21 (quiz 22-23) (Pubitemid 43946484)
95. S.M. Langan, and A.D. Irvine Childhood eczema and the importance of the physical environment J. Invest. Dermatol. 133 2013 1706 1709
96. I.R. Scott, and C.R. Harding Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment Dev. Biol. 115 1986 84 92 (Pubitemid 16118872)
97. A. Garg, M.M. Chren, L.P. Sands, M.S. Matsui, K.D. Marenus, K.R. Feingold, and P.M. Elias Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders Arch. Dermatol. 137 2001 53 59 (Pubitemid 32096358)
98. E.H. Choi, B.E. Brown, D. Crumrine, S. Chang, M.Q. Man, P.M. Elias, and K.R. Feingold Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity J. Invest. Dermatol. 124 2005 587 595 (Pubitemid 40381582)
99. J.L. Santiago, T.K. Lin, M.Q. Man, M. Hupe, G. Martin-Ezquerra, and P.M. Elias Paradoxical benefits of psychological stress in mouse models of inflammatory dermatoses IID 2013, vol. 133, Edinburgh, Scotland 2013 S114
100. T. Bieber, M. Cork, and S. Reitamo Atopic dermatitis: a candidate for disease-modifying strategy Allergy 67 2012 969 975
101. M. Loden Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders Am. J. Clin. Dermatol. 4 2003 771 788 (Pubitemid 37452637)
102. M.J. Cork, J. Britton, L. Butler, S. Young, R. Murphy, and S.G. Keohane Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse Br. J. Dermatol. 149 2003 582 589 (Pubitemid 37281592)
103. L.H. Kircik, J.Q. Del Rosso, and D. Aversa Evaluating clinical use of a ceramide-dominant, physiologic lipid-based topical emulsion for atopic dermatitis J. Clin. Aesthetic Dermatol. 4 2011 34 40
104. J. Bikowski Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis J. Drugs Dermatol. 8 2009 1037 1041
105. Y. Uchida, W.M. Holleran, and P.M. Elias On the effects of topical synthetic pseudoceramides: comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramides J. Dermatol. Sci. 51 2008 37 43
106. Y.B. Lee, H.J. Park, M.J. Kwon, S.K. Jeong, and S.H. Cho Beneficial effects of pseudoceramide-containing physiologic lipid mixture as a vehicle for topical steroids Eur. J. Dermatol. 21 2011 710 716
107. J. Sugarman, and L.J. Parish A topical lipid-based barrier repair formulation (EpiCeram cream) is high-effective monotherapy for moderate-to-severe pediatric atopic dermatitis IID 2008 Kyoto, Japan 2008
108. Y. Valdman-Grinshpoun, D. Ben-Amitai, and A. Zvulunov Barrier-restoring therapies in atopic dermatitis: current approaches and future perspectives Dermatol. Res. Prac. 2012 2012 923134
109. A. Madaan Epiceram for the treatment of atopic dermatitis Drugs Today (Barc) 44 2008 751 755
110. U.M. Houtsmuller, and A. van der Beek Effects of topical application of fatty acids Prog. Lipid Res. 20 1981 219 224
111. M.M. McCusker, and J.M. Grant-Kels Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids Clin. Dermatol. 28 2010 440 451
112. R.H. Foster, G. Hardy, and R.G. Alany Borage oil in the treatment of atopic dermatitis Nutrition 26 2010 708 718
113. C. De Belilovsky, E. Roo-Rodriguez, C. Baudouin, F. Menu, B. Chadoutaud, and P. Msika Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis J. Dermatol. Treat 22 2011 359 365
114. C. Furuhjelm, K. Warstedt, M. Fageras, K. Falth-Magnusson, J. Larsson, M. Fredriksson, and K. Duchen Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation Pediatr. Allergy Immunol. 22 2011 505 514
115. L.S. Kremmyda, M. Vlachava, P.S. Noakes, N.D. Diaper, E.A. Miles, and P.C. Calder Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review Clin. Rev. Allergy Immunol. 41 2011 36 66
116. S. Senapati, S. Banerjee, and D.N. Gangopadhyay Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled trial Indian J. Dermatol. Venereol. Leprology 74 2008 447 452
117. J. Duan, T. Sugawara, M. Hirose, K. Aida, S. Sakai, A. Fujii, and T. Hirata Dietary sphingolipids improve skin barrier functions via the upregulation of ceramide synthases in the epidermis Exp. Dermatol. 21 2012 448 452
118. M. Amestejani, B.S. Salehi, M. Vasigh, A. Sobhkhiz, M. Karami, H. Alinia, S.K. Kamrava, N. Shamspour, B. Ghalehbaghi, and A.H. Behzadi Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study J. Drugs. Dermatol. 11 2012 327 330
119. K.Y. Park, D.H. Kim, M.S. Jeong, K. Li, and S.J. Seo Changes of antimicrobial peptides and transepidermal water loss after topical application of tacrolimus and ceramide-dominant emollient in patients with atopic dermatitis J. Korean Med. Sci. 25 2010 766 771
120. S.J. Galli, M. Tsai, and A.M. Piliponsky The development of allergic inflammation Nature 454 2008 445 454
121. A. De Benedetto, C.M. Qualia, F.M. Baroody, and L.A. Beck Filaggrin expression in oral, nasal, and esophageal mucosa J. Invest. Dermatol. 128 2008 1594 1597 (Pubitemid 351693198)